Carrier Is Synthetic Resin Patents (Class 436/531)
-
Patent number: 5449625Abstract: The present invention relates to an apparatus for performing a fluoroimmunoassay, the apparatus comprising an excitation light source, a fluorescence detector, an optical fiber for an excitation light from the excitation light source to which an antigen or antibody is bound, and a spectroscope, in which the mentioned antigen or antibody is bound to an outgoing end surface of the optical fiber for the excitation light. In the apparatus the spectroscope is constructed so that it introduces the excitation light emitted from the excitation light source to a incident end surface of the optical fiber for the excitation light and introduces a fluorescence emitted from a fluorescence-labeled antibody or antigen which forms an immunological complex with the antigen or antibody to the fluorescence detector. In the apparatus the outgoing end surface of the optical fiber for the excitation light has a transmittance for the excitation light from the excitation light source.Type: GrantFiled: August 16, 1993Date of Patent: September 12, 1995Assignee: Ibiden Co., Ltd.Inventors: Takeshi Kobayashi, Shinji Iijima, Yasunori Sakai, Ken-ichi Shimada
-
Patent number: 5447837Abstract: The present invention provides a test strip for detecting, in a sample from a human subject, the presence of an antigenic substance which comprises a solid support, an antibody directed against the antigenic substance bound to a first discrete area on the solid support, an anti-human antibody bound to a second discrete area on the solid support as a positive control, and an antibody directed against an antigen which does not naturally occur in human subjects bound to a third discrete area on the solid support as a negative control. The present invention also provides a test strip for detecting, in a sample from a human subject, the presence of an antibody which comprises a solid support, an antigenic substance bound to a first discrete area on the solid support, an anti-human antibody bound to a second discrete area on the solid support as a positive control, and a negative control bound to a third discrete area on the solid support.Type: GrantFiled: February 6, 1989Date of Patent: September 5, 1995Assignee: Calypte, Inc.Inventor: Howard B. Urnovitz
-
Patent number: 5447870Abstract: Disclosed is a primary chromatographic support containing an immobilized flocculating agent for use as a separation media for a secondary support consisting of microparticles used in affinity separation and heterogeneous immunoassays. In a specific embodiment, a flocculating agent such as polyethyleneimine is immobilized on a chromatographic resin packed in a column. The column so formed is then used to trap microparticles having an affinity ligand or binder for the ligand affixed thereon. Such microparticles are used as a solid support for the affinity reaction involved in a variety of immunoassay formats.Type: GrantFiled: October 29, 1993Date of Patent: September 5, 1995Assignee: E. I. Du Pont de Nemours and CompanyInventor: Hon-Peng P. Lau
-
Patent number: 5441895Abstract: A stack of a plurality of substantially identical cup-like vessels pre-incorporated with reagent on the inside, each of the vessels occupying at least about 50% of the depth of the next adjacent vessel to maximize stacking density. Because the pre-incorporated reagent overlaps the occupied depth portion of the vessel and therefore runs a risk of being dislodged, the wall of the vessel is constructed to provide a gap between the inside surface bearing the reagent, and the outside surface of the occupying, nested vessel, that is at least 0.025 mm.Type: GrantFiled: December 7, 1993Date of Patent: August 15, 1995Inventors: Raymond F. Jakubowicz, Johannes J. Porte
-
Patent number: 5439792Abstract: Peptides immunoreactive with antibodies to native proteins, and which have at least two cysteine residues that contribute to mimicking an epitope of the protein, are prepared with the cysteine thiol groups protected. When deprotected, the peptides have enhanced immunoreactivity. The peptides are particularly useful for detecting antibodies or antigens associated with retroviruses, including the clinically important lymphotropic retroviruses HIV-1, HIV-2, HTLV-I, and HTLV-II.Type: GrantFiled: October 21, 1993Date of Patent: August 8, 1995Assignee: Genetic Systems CorporationInventors: James Blake, Carol-Ann Cole, Patrick F. Coleman, Nobuo Monji, John P. Montana
-
Patent number: 5439830Abstract: In an immunoassay for determining the amount of a target substance in a sample using photothermal deflection spectroscopy to determine the amount of bound label, a sandwich procedure is used which comprises reacting the target substance with two antibodies or antigens, one labelled with a compound having photothermal deflection activity, and the other immobilized on a carrier capable of amplifying that photothermal conversion activity of the label.Type: GrantFiled: October 20, 1993Date of Patent: August 8, 1995Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Hajime Sakashita, Hiroshi Kishioka, Shohei Konishi, Tsuguo Swada, Takahiko Kitamori
-
Patent number: 5439799Abstract: The invention relates to an agent and process for treating body fluids in the immunological determination of neopterin using a specific antibody against neopterin and a detection system. The agent is characterized in that it contains an oxidizing agent.Type: GrantFiled: May 7, 1993Date of Patent: August 8, 1995Assignee: Merck Patent Gesellschaft mit Beschrankter HaftungInventors: Wilfried Rautenberg, Arnulf Heubner
-
Patent number: 5437983Abstract: A method for carrying out a binding assay is described wherein a member of a specific binding pair (sbp) and a sample are combined with a matrix of non-porous beads in a liquid medium under conditions such that the beads bind to the sbp member. The liquid medium is removed from the beads by aspiration using an aspiration tube having one or more orifices each of a diameter smaller than the minimum diameter of the smallest bead thereby allowing removal of the liquid medium while prohibiting aspiration of the beads.Type: GrantFiled: February 1, 1993Date of Patent: August 1, 1995Assignee: Syntex (U.S.A.) Inc.Inventors: Richard P. Watts, Mary C. Ericson, Hrair Kirakossian, Chiu C. Chang
-
Patent number: 5437987Abstract: A method for separating nucleated fetal red blood cells and nucleated fetal cells and maternal granular sites from maternal blood is achieved by applying maternal blood to a triple gradient gel, isolating nucleated fetal cells from the gel and binding the isolated fetal cells to a solid support by means of an anti-i antibody bound to the solid support. The separated fetal cells can then be subjected to analysis for fetal sex or genetic disorders.Type: GrantFiled: June 14, 1993Date of Patent: August 1, 1995Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Nelson N. H. Teng, Marcia Bieber, Neelima M. Bhat
-
Patent number: 5434088Abstract: A target substance is detected by a sandwich immunoassay using fine particle (A) having bound to it a fluorescer and an antibody reacting specifically with the target substance, and a fine particle (B) having bound to it a quencher and an antibody reacting specifically with the target substance, through a different antigenic determinant. Also disclosed is a competitive immunoassay having a fine particle (C) bound to it a fluorescer or a quencher, and an antibody reacting specifically with the target substance, a bound product (D) composed of the remainder of the fluorescer and the quencher, or a known amount of the target substance. Binding of the fluorescer and the quencher to the fine particle (A), (B) or (C) is affected so that the fluorescer and the quencher are covalently bound to a substance adsorbed on the fine particle.Type: GrantFiled: May 24, 1994Date of Patent: July 18, 1995Assignee: Tosoh CorporationInventors: Kenji Ikeda, Kazuhisa Toyoda, Hideo Suzuki
-
Patent number: 5432100Abstract: In a diagnostic apparatus system, a one piece porous substrate is provided in a container. The substrate serves both to extract an antigen in or on a top layer thereof with the remainder of the substrate serving as a reservoir. The pores in the top surface of the substrate are microscopic for entrapment of microspheres carrying antibodies. A target antigen in a test sample attaches to the antibodies when the test sample is poured through the top layer. The pores in all but the top layer of the substrate have a much greater pore size to comprise tile reservoir portion of the substrate.Type: GrantFiled: December 13, 1991Date of Patent: July 11, 1995Assignee: Porex Technologies Corp.Inventors: Michael W. Smith, Robert S. Pierce
-
Patent number: 5429929Abstract: The subject invention provides an antigen characterized as having a molecular weight of approximately 68 kD, being reactive with autoantibodies associated with mental illness especially schizophrenia, being located in neuronal cells, and co-migrating with a protein band in SDS-PAGE which is recognized by rabbit antibodies which react with the peptide whose sequence is Ala-Lys-Xaa-Val-Lys-Phe-Gly-Ala-Asp-Ala-Xaa-Ala-Leu-Met-Leu (SEQ ID NO: 2). The invention also provides methods for detecting in a sample from a subject the presence of an antibody to the neuronal antigen, determining the propensity of a subject toward a psychiatric disease, diagnosing and treating a subject having mental illness.Type: GrantFiled: April 19, 1991Date of Patent: July 4, 1995Assignee: The Trustees of Columbia University in the City of New YorkInventors: Norman Latov, Saud A. Sadiq, Jack M. Gorman, Costas Kilidireas
-
Patent number: 5429925Abstract: A method is described for the use of monoclonal antibodies in a sensitive immunoassay for halogenated dioxins and dibenzofurans in industrial samples which contain impurities. Appropriate sample preparation and selective enzyme amplification of the immunoassay sensitivity permits detection of dioxin contaminants in industrial or environmental samples at concentrations in the range of a few parts per trillion.Type: GrantFiled: October 26, 1992Date of Patent: July 4, 1995Assignee: The Regents of the University of CaliforniaInventors: Martin Vanderlaan, Larry H. Stanker, Bruce E. Watkins, Peter Petrovic, Siegbert Gorbach
-
Patent number: 5427959Abstract: On a slab-like board formed of a transparent material is closely attached a wedge-shaped transparent cover member provided with a recess in a central inner portion, thereby to form a clearance. The height of the clearance between the recess and the board is configured to decrease continuously or in steps. When an immunological active substance such as a monoclonal antibody is caused to sensitize carrier particles F, and a reagent having the carrier particles F dispersed into a liquid medium mainly composed of the water is mixed with a specimen, the reaction will occur in which the flocculate is formed from plural carrier particles. When this reaction liquid is poured into the clearance through the opening, the reaction liquid penetrates in the direction having a narrower vertical spacing due to surface tension. A single carrier particle unflocculated can move deep within the recess because it is small in diameter, but the flocculate G is trapped on its way and can not move because of its size.Type: GrantFiled: October 1, 1991Date of Patent: June 27, 1995Assignee: Canon Kabushiki KaishaInventors: Matsuomi Nishimura, Kazumi Tanaka, Takeshi Miyazaki, Hidehito Takayama, Toshikazu Ohnishi
-
Patent number: 5424219Abstract: Methods of performing an assay for biomolecules and solid supports for use in such assays are disclosed. An activated polymeric material is used as a solid support for binding biomolecules. In a preferred form, the support is made of a generally hydrophobic, nonporous polymer which has been activated by treatment with solvents or by mechanical means to enhance the binding characteristics of the support. The support can be made of a copolymer, such as a copolymer of polystyrene and polybutadiene. Detection of bound biomolecules is preferably performed by means of staining reactions and gray level scanning. Emulsifying agents, such as detergents, can be applied to the surface of the support to substantially inhibit additional materials from being bound to the support.Type: GrantFiled: October 25, 1991Date of Patent: June 13, 1995Assignee: Cytech Biomedical, Inc.Inventor: Gustav F. Jirikowski
-
Patent number: 5422239Abstract: Hybridomally produced monoclonal IgM antibodies having high affinity are useful for the immunoassay and purification of vital antigens.Type: GrantFiled: May 15, 1987Date of Patent: June 6, 1995Assignee: General Hospital CorporationInventors: Jack R. Wands, Vincent R. Zurawski, Jr.
-
Patent number: 5422284Abstract: Disclosed is a primary chromatographic support containing an immobilized flocculating agent for use as a separation media for a secondary support consisting of microparticles used in affinity separation and heterogeneous immunoassays. In a specific embodiment, a flocculating agent such as polyethyleneimine is immobilized on a chromatographic resin packed in a column. The column so formed is then used to trap microparticles having an affinity ligand or binder for the ligand affixed thereon. Such microparticles are used as a solid support for the affinity reaction involved in a variety of immunoassay formats.Type: GrantFiled: October 29, 1993Date of Patent: June 6, 1995Assignee: E. I. Du Pont de Nemours and CompanyInventor: Hon-Peng P. Lau
-
Patent number: 5420275Abstract: An assay method which comprises utilizing chemiluminescence of a pyridopyridazine compound of the formula ##STR1## wherein R.sub.1 is a hydrocarbon group or a heterocyclic group each of which may be substituted and R.sub.2 is hydroxy group, thiol group, amino group or a monosubstituted amino group, and when R.sub.2 is a monosubstituted amino group, R.sub.2 may be taken together with R.sub.1 to form the ring; R.sub.3 is hydrogen atom, a hydroxy group which may be substituted, an amino group which may be substituted, a thiol group which may be substituted, a halogen atom, a heterocyclic group, nitro group, cyano group, carboxyl group which may be esterified or amidated, azido group, sulfo group or an organic sulfonyl group, provided that when R.sub.1 is an aliphalic group, R.sub.3 is not hydrogen atom; and X is oxygen atom or sulfur atom/or a salt thereof; and a novel compound of the formula (I) wherein the symbols are as defined above with proviso that R.sub.3 is hydrogen atom, R.sub.Type: GrantFiled: November 2, 1993Date of Patent: May 30, 1995Assignee: Takeda Chemical Industries, Ltd.Inventors: Hirotomo Masuya, Yoshio Aramaki
-
Patent number: 5420014Abstract: The present invention contemplates a method for detecting contempory infection by H. pylori in a mammal comprising contacting a mucous secretion from said mammal with an antigen component from H. pylori for a time and under conditions sufficient for an IgG antibody in said mucous secretion specific to said antigen component to form a complex therewith and then subjecting said complex to a detecting means. Preferably, the antigen component is immobilized onto a solid support.Type: GrantFiled: April 30, 1992Date of Patent: May 30, 1995Assignee: Auspharm International Ltd.Inventors: Allan Cripps, Campbell Witt, Robert L. Clancy, Daniel Stiel
-
Patent number: 5420012Abstract: The invention relates to diagnosis of reactive conditions, such as malignant tumors. According to the invention, the amount of cellular fibronectin in a body fluid is determined, and an elevated amount is used as a marker for a reactive condition. The method is especially suitable for the diagnosis of carcinomas, such as colon carcinoma.Type: GrantFiled: October 23, 1992Date of Patent: May 30, 1995Assignee: Locus Genex OyInventors: Paul Partanen, Sari Ylatupa, Raili Paasivuo, Ismo Virtanen
-
Patent number: 5420047Abstract: Immunodiagnostic tests in which enzymes or antibodies are bound to porous carrier materials can be carried out by employing as porous carrier materials macroporous polymer membranes which are prepared by(a) dispersing an insoluble filler in a solution which contains at least two incompatible polymers in amounts which lead to phase separation in the solution, resulting in a homogeneous casting solution, and(b) applying this solution to a support and carrying out a precipitation coagulation.Type: GrantFiled: November 12, 1993Date of Patent: May 30, 1995Assignee: Bayer AktiengesellschaftInventors: Heinz-Dieter Brandt, Rolf Dhein, Karlheinz Hildenbrand, Ronald Stocker
-
Patent number: 5418136Abstract: Optical assay device having an active receptive surface supported on a pedestal and held within a first container; the first container comprising first absorbent material located at the base of the pedestal, configured and arranged to absorb liquid draining from the surface, and having a second container, hingedly connected to one side of the first container, the second container comprising a second absorbent material, wherein the second container can be closed to the first container by rotation about the hinge, and wherein such closing causes the second absorbent material to contact the surface.Type: GrantFiled: June 10, 1993Date of Patent: May 23, 1995Assignee: Biostar, Inc.Inventors: B. John Miller, Diana M. Maul, James Blessing, Mark Crosby, Howard Kelley
-
Patent number: 5416001Abstract: A method for detecting an analyte is disclosed in which the analyte is brought into contact with at least one receptor which is bound to or can be bound to a solid phase. In order to avoid unspecific interferences the addition of a glycosidic surfactant is proposed.Type: GrantFiled: June 25, 1993Date of Patent: May 16, 1995Assignee: Boehringer Mannheim GmbHInventors: Peter Sluka, Rainer Wehner
-
Patent number: 5413939Abstract: A solid-phase binding assay that measures interferometrically either antibodies or binding pair antigens bound to a spinning disc on which the complementary antigen or antibody has previously been coated in an alternating pattern of immunologically active and inactive spots. The spinning disc is inserted into one arm of a Mach-Zehnder interferometer and as the disc spins the bound and unbound spots pass one after another through the two light beams causing a periodic phase shift in the light. These phase modulated light beams are then recombined at a beam-splitter converting the phase modulation into an amplitude modulation. The two recombined beams then fall on a photodetector which converts the periodically varying optical power into a periodically varying electrical current whose amplitude is proportional to the amount of bound protein on the surface of the disc and whose modulation frequency is equal to the frequency with which the spots pass through the light beam.Type: GrantFiled: June 29, 1993Date of Patent: May 9, 1995Assignee: First Medical, Inc.Inventors: Eric K. Gustafson, Jimmy D. Allen, Michael E. Cobb
-
Patent number: 5405785Abstract: This invention provides a molecule comprising cyclosporine A or a congener of cyclosporine A which is photochemically attached to a ligand containing a reactive group. This invention also provides a composition of matter which comprises a conjugate of a compound and the aforementioned molecule wherein the compound is bound to the molecule through the reactive group. This invention further provides an antibody directed to the aforementioned composition of matter specific for cyclosporine A or congener of cyclosporine A. Finally, this invention provides a method of monitoring levels of cyclosporine A or congener of cyclosporine A in a subject.Type: GrantFiled: January 15, 1993Date of Patent: April 11, 1995Assignee: The Trustees of Columbia University in the City of New YorkInventors: Bernard F. Erlanger, William L. Cleveland, Nicholas A. Cacalano
-
Patent number: 5405618Abstract: A biomosaic polymer is provided. Biologically active materials are bound at surfaces of such polymers polymerized from emulsions containing hydrophobic polymerizable monomers, such biologically active materials, and surface active agents. The biomosaic polymers may be formed into membranes, films, beads, or other structures for a variety of assays, bioseparations, or catalyzed reactions and other uses. A single step polymerization of the emulsion provides significant retention of the biologically active material bound and congregated at surfaces of the polymer.Type: GrantFiled: November 5, 1992Date of Patent: April 11, 1995Assignee: Minnesota Mining and Manufacturing CompanyInventors: Howard J. Buttery, Patrick L. Coleman, Dean S. Milbrath
-
Patent number: 5405752Abstract: The invention relates to a reagent consisting of at least one enzyme and at least one other substance, which are covalently or noncovalently bound to a particle, which is smaller than or is equal to 1000 Angstrom in diameter. The invention also relates to method and use of the reagent for determination or studies of a cell or a virus or another component in a sample. According to the invention, these determinations are made with for example some ELISA-technique (competitive, sandwich, etc), employing the reagent preferably in the form of a suspension in buffered water, instead of and in the same way as described for soluble enzyme conjugates. The substance can be antibody, a lectin, avidin or an antigen, the enzyme can be for example peroxidase, alcaline phosphatase, and the particle can be an inorganic or an organic polymeric compound or a combination thereof, as, for example, tresyl-activated glycerylpropyl-silica.Type: GrantFiled: January 14, 1994Date of Patent: April 11, 1995Inventor: Kurt G. I. Nilsson
-
Patent number: 5405784Abstract: The invention provides a method capable of determining the presence or absence of each of a plurality of different ligands in a specimen. The specimen is contacted with a predetermined number of different homogeneous populations of fluorescence beads having one or more predetermined antiligands affixed to their surface. The specimen and bead mixture is analyzed using a means having a single parameter for measuring the fluorescence per ligand to determine the number of nonagglutinated beads, the number of agglutinated beads, the number of bead aggregates, and for each aggregate, the number of beads it comprises. This information is used to correlate the presence or absence in the specimen of each of the different ligands analyzed for. The method of the invention thus provides for the simultaneous determination of a predetermined number of ligands in a specimen using only a single bead contacting step.Type: GrantFiled: February 25, 1993Date of Patent: April 11, 1995Assignee: ChemunexInventor: Michel Van Hoegaerden
-
Patent number: 5403745Abstract: A method is provided, in one embodiment, for the determination of an analyte in a biological fluid sample in the presence of a substance interfering with an assay for the analyte. This embodiment is implemented by using antibodies to cause the selective immunoreaction of at least one of the analyte or the interfering substance and then conducting an assay for the analyte in at least one of the immunoreactants or the non-reactants. Another embodiment provides a disposable reaction device to implement the method. The invention is applicable to the detection of a wide variety of analytes, including cholesterol in a targeted lipoprotein class in the presence of cholesterol in another class; to targeted isozymes of enzymes such as creatine kinase, lactate dehydrogenase, amylase, and alkaline or acid phosphatases in the presence of other isozymes; as well as to targeted immunoglobulins in the presence of non-targeted immunoglobulins.Type: GrantFiled: April 27, 1990Date of Patent: April 4, 1995Assignee: Genzyme CorporationInventors: James F. Ollington, Ronald J. Byrnes, Donald E. Pogorzelski
-
Patent number: 5403750Abstract: Affinity matrices useful for the chromatography and immobilization of biological materials and the method of preparing and using the same are disclosed. The affinity supports are based on hydrated polyurethane polymers which have been activated to provide a means for covalently attaching a variety of bioaffinity agents. The hydrated polymer matrices are characterized by their biocompatibility and resistance to nonspecific protein adsorption. Preferably, the prepolymers used to prepare the hydrated polymers are isocyanate-capped oxyethylene-based diols or polyols, at least 75% of said diols and polyols having a molecular weight of 7000 to about 30,000.Type: GrantFiled: April 8, 1991Date of Patent: April 4, 1995Assignee: W. R. Grace & Co.-Conn.Inventors: James A. Braatz, Aaron H. Heifetz
-
Patent number: 5403706Abstract: A carrier matrix of polyvinyl alcohol-coated glass is dissolvably impregnated with reagent. The matrix is manufactured by slurrying glass fibers in an excess of water and polyvinyl alcohol and forming a layer, which is then dried and impregnated with reagent.Type: GrantFiled: July 20, 1989Date of Patent: April 4, 1995Assignee: Boehringer Mannheim GmbHInventors: Hans-Erich Wilk, Dieter Mangold, Rolf Lerch, Joachim Steinbiss
-
Patent number: 5401636Abstract: An agglutination-based method for detecting and/or an analyte by allowing the agglutination reaction between the analyte, a carrier reagent, and an agglutinating agent to occur in the presence of a multivalent ligand.Type: GrantFiled: November 23, 1993Date of Patent: March 28, 1995Assignee: E. I. Du Pont de Nemours and CompanyInventor: Alan R. Craig
-
Patent number: 5399500Abstract: A process for coating an antibody on a substrate includes two steps. A secondary antibody to a primary antibody is coated on the substrate followed by a coating with primary antibody in the presence of blocking and stabilizer agents.Type: GrantFiled: June 26, 1992Date of Patent: March 21, 1995Assignee: Becton Dickinson and CompanyInventors: Leslie Oppenheimer, Lewis R. Pollack
-
Patent number: 5397695Abstract: Useful materials for diagnostic tests, affinity chromatography, enzymatic reactions and immunoassays are prepared by covalently attaching reactive compounds containing reactive amino or sulfhydryl groups to polymeric particles having pendant carboxyl groups on the outer surfaces. Such reactive compounds include biologically reactive species, such as enzymes, polypeptides and proteins. This attachment is carried out using carbamoylonium compounds which react with the carboxyl groups to form intermediate reactive groups which then react with the amino or sulfhydryl groups to form a covalent linkage between particle and reactive compound. A kit comprises polymeric particles having carboxyl groups on the outer surfaces, and a carbamoylonium compound.Type: GrantFiled: June 29, 1989Date of Patent: March 14, 1995Assignee: Eastman Kodak CompanyInventors: Richard C. Sutton, Susan J. Danielson, Pranab Bagchi, Patricia M. Scensny
-
Patent number: 5397712Abstract: A method to aid in the diagnosis of Alzheimer's disease in a living patient is disclosed which tests cerebrospinal fluid (CSF) obtained from the patient. The CSF is tested using a Western blot analysis to determine the presence of an antigen present in soluble paired helical filaments which specifically binds to the monoclonal antibody produced by hybridoma ATCC HD11079.Type: GrantFiled: July 28, 1992Date of Patent: March 14, 1995Assignee: University of CincinnatiInventors: Frank P. Zemlan, Gary E. Dean
-
Patent number: 5395754Abstract: The present invention is directed to a membrane-based immunoassay method for an analyte of interest having at least two sterically separate antigenic sites. The method comprises providing a reactive membrane having a calibration zone and a test zone, wherein the calibration zone is characterized by having a predetermined amount of the analyte of interest immobilized via a first antibody as a first specific binding pair to a solid phase, the immobilized first binding pair being covalently cross-linked such that any remaining binding sites on said first immobilized antibody are substantially incapable of further specifically binding to any additional analyte, but at least some of said analyte is capable of specifically binding to a preselected amount of a labelled second antibody.Type: GrantFiled: July 31, 1992Date of Patent: March 7, 1995Assignee: Hybritech IncorporatedInventors: Paul P. Lambotte, Robert C. Darter, Mark J. Sarno
-
Patent number: 5393659Abstract: Agents for immunochemical tests which contain polymers containing carboxyl groups and processes for carrying out such tests are described. These polymers are capable of improving the results obtained with such tests, in that they suppress non-specific reactions and increase the sensitivity of the tests.Type: GrantFiled: December 23, 1992Date of Patent: February 28, 1995Assignee: Behringwerke AktiengesellschaftInventors: Michael Noah, Rudolf Schmidtberger
-
Patent number: 5389533Abstract: Biochemical substances such as enzymes are immobilized by reaction with epoxy groups of an olefinic-unsaturated, epoxyfunctional polyether. Prior to immobilization, the polyether is applied to a carrier and crosslinked by treatment with high-energy radiation or peroxide to form a layer. After reacting the biochemical substance with epoxy groups, non-reacted epoxy groups are reacted with a compound containing an amino group and/or a carboxyl group such as an amino acid. Before immobilizing of the biochemical substance and after crosslinking, the polyether may be hydrophilized by reacting some of the epoxy groups with a hydrophilic compound such as an amino acid.Type: GrantFiled: March 22, 1993Date of Patent: February 14, 1995Assignee: Siemens AktiengesellschaftInventors: Wolfgang von Gentzkow, Hans-Dieter Feucht
-
Patent number: 5389518Abstract: The present invention provides monoclonal antibodies directed against specific domains of fibronectin and vitronectin. These monoclonals may be used in the production of the biomaterial and devices for use in in vitro cell culture. The present invention also provides an efficient method for extracting vitronectin from bovine serum or plasma using monoclonal antibodies and methods for analyzing biological samples for the presence of adhesive glycoproteins or fragments thereof.Type: GrantFiled: August 1, 1994Date of Patent: February 14, 1995Assignee: Commonwealth Scientific and Industrial Research OrganisationInventors: John G. Steele, Patricia A. Underwood
-
Patent number: 5389534Abstract: A biosensor is prepared having a selective detection system containing a biochemical substance such as an enzyme immobilized by reaction with epoxy groups of an olefinic-unsaturated, epoxyfunctional polyether. Prior to immobilization, the polyether is applied to a carrier and crosslinked by treatment with high-energy radiation or peroxide to form a layer. After reacting the biochemical substance with epoxy groups, non-reacted epoxy groups are reacted with a compound containing an amino group and/or a carboxyl group such as an amino acid. Before immobilizing of the biochemical substance and after crosslinking, the polyether may be hydrophilized by reacting some of the epoxy groups with a hydrophilic compound such as an amino acid.Type: GrantFiled: March 22, 1993Date of Patent: February 14, 1995Assignee: Siemens AktiengesellschaftInventors: Wolfgang von Gentzkow, Hans-Dieter Feucht
-
Patent number: 5384244Abstract: The present disclosure is directed to a peptide having active binding sites in a protein wherein the binding sites attract and hold antibodies for schistosomiasis in humans. A test reagent is set forth. Separate binding sites in the complex protein have been identified, and the binding sites in such reagent define the mechanism whereby the antibodies in the human serum provide a test reaction.Type: GrantFiled: October 13, 1992Date of Patent: January 24, 1995Inventors: Cynthia L. Chappell, Marc H. Dresden, deceased, by Judith H. Dresden, legal representative
-
Patent number: 5384261Abstract: A method and device for forming large arrays of polymers on a substrate (401). According to a preferred aspect of the invention, the substrate is contacted by a channel block (407) having channels (409) therein. Selected reagents are flowed through the channels, the substrate is rotated by a rotating stage (403), and the process is repeated to form arrays of polymers on the substrate. The method may be combined with light-directed methodolgies.Type: GrantFiled: November 22, 1991Date of Patent: January 24, 1995Assignee: Affymax Technologies N.V.Inventors: James L. Winkler, Stephen P. A. Fodor, Christopher J. Buchko, Debra A. Ross, Lois Aldwin
-
Patent number: 5382513Abstract: The instant invention provides a library of bio-oligomers of defined size and known composition, in which the library contains all of the possible sequences of the bio-oligomers, and a method of synthesis thereof. The bio-oligomers of the library may be peptides, nucleic acids, or a combination of the foregoing. The instant invention also provides methods to identify bio-oligomers from a library that demonstrate desired characteristics such as binding, bioactivity and catalytic activity. Thus the instant invention provides a unique and powerful method to identify a useful bio-oligomer sequences from a library more quickly than current state-of-the-art technology allows. Effector molecules for use in treatment or diagnosis of disease are also provided.Type: GrantFiled: February 8, 1993Date of Patent: January 17, 1995Assignee: Bioligand Inc.Inventors: Kit S. Lam, Sydney E. Salmon
-
Patent number: 5380658Abstract: A phosphazene polymer carrier is prepared that has functional groups capable of binding a biologically active substance such as an enzyme or antibody and groups which are non-reactive and hydrophilic. A bifunctional aldehyde is reacted with primary amino groups of a shaped phosphazene polymer to form side chains having aldehyde groups, an amino group-containing compound is reacted with a portion of the aldehyde groups to produce the groups that are non-reactive and hydrophilic, and aldehyde groups not reacted are capable of binding a biologically active substance. The phosphazene polymer may be crosslinked prior to reacting with the bifunctional aldehyde.Type: GrantFiled: September 16, 1993Date of Patent: January 10, 1995Assignee: Teijin LimitedInventors: Toshitsugu Matsuki, Noritsugu Saiki, Shingo Emi
-
Patent number: 5378638Abstract: An analysis element for the determination of an analyte in a liquid sample, especially for medicinal uses. A carrier layer (2) contains, in a reagent domain (4), a reagent applied in a defined pattern by an ink-jet process. The pattern comprises several sets (A, B, C) of compartments (11-20), the compartments (e.g. 11, 13, 15, 17, 19) of the same set (e.g. A) having the same chemical composition, the compartments (11, 13, 15, 17, 19 or 12, 16, 20) of different sets (A or B) containing different reagents and the compartments of different sets being arranged in alteration so that the compartments containing different reagents are close together but nevertheless spatially separated.Type: GrantFiled: May 20, 1993Date of Patent: January 3, 1995Assignee: Boehringer Mannheim GmbHInventors: Rolf Deeg, Eberhard Maurer, Sigmar Klose, Bernhard Kopfer, Reiner Babiel
-
Patent number: 5374529Abstract: Methods of and compositions for early diagnosis, monitoring and treatment of osteoarthritis using monoclonal antibodies which specifically recognize antigenic determinants on atypical chondroitin sulfate/dermatan sulfate glycosaminoglycan chains in body tissues and fluids, which determinants are markers of osteoarthritis.Type: GrantFiled: November 1, 1991Date of Patent: December 20, 1994Inventors: Bruce Caterson, Timothy E. Hardingham
-
Patent number: 5374516Abstract: Reagents have been prepared from water-insoluble polymeric particles to which are covalently attached avidin, biotin or an avidin or biotin derivative. The polymeric particles comprise a polymer on at least the outer surface which is derived from at least one ethylenically unsaturated monomer having a reactive activated 2-substituted ethylsulfonyl, vinylsulfonyl or active halogen atom. Covalent attachment of avidin, biotin or an avidin or biotin derivative is effected either directly or indirectly through these reactive groups. The resulting reagent is useful in analytical elements and various analytical methods including agglutination and sandwich assays. The immobilized avidin, biotin or derivative can be used to complex with the corresponding biotin or avidin molecule which may be conjugated to a compound of biological interest.Type: GrantFiled: February 24, 1989Date of Patent: December 20, 1994Assignee: Eastman Kodak CompanyInventors: Richard C. Sutton, Brent A. Burdick, Susan J. Danielson, Harold C. Warren, III, Brian A. Snyder, Gregory J. McClune, Annie L. Wu
-
Patent number: 5372948Abstract: Disclosed are a method and device for performing sequential analytical reactions involving a first dry reagent and a second dry reagent comprised of two or more components having different rates of solubilization. The invention enables one to fully solubilize the components of the second reagent before they are brought into contact with each other to thereby avoid interference with the reaction kinetics which result when one or both of the components are not fully dissolved prior to their being brought into contact. The invention is especially useful in conjunction with immunoassay formats involving latex bound antibodies and polymeric agglutinators.Type: GrantFiled: March 17, 1993Date of Patent: December 13, 1994Assignee: Miles Inc.Inventor: Kin F. Yip
-
Patent number: 5372930Abstract: A sensor for ultra-low concentration chemical recognition comprises a force transducer, a tip coupled to this force transducer, and a substrate positioned for force interaction with the force transducer tip, where the substrate and tip are chemically modified with antigens, antibodies, nucleic acids, or chelating agents so that there is a specific force interaction between the tip and the substrate in the presence of the target species, and a measurably different force interaction in the absence of the target species.Type: GrantFiled: September 16, 1992Date of Patent: December 13, 1994Assignee: The United States of America as represented by the Secretary of the NavyInventors: Richard J. Colton, David A. Kidwell
-
Patent number: RE34864Abstract: The present invention provides a carrier for coating with immunologically-active material, wherein it consists of an injection molded synthetic resin with a content of adjuvant and additional materials of less than 1% by weight. The present invention also provides a carrier coated with immunologically-active material, wherein the carrier consists of synthetic resin with a content of adjuvant and additional materials of less than 1% by weight.Type: GrantFiled: December 1, 1992Date of Patent: February 21, 1995Assignee: Boehringer Mannheim GmbHInventors: Hans-Georg Batz, Herbert Hopp, Klaus Stellner